Biotech

Latest Articles

Cassava pays for $40M over supposedly deceptive Alzheimer's update

.Cassava Sciences has accepted to pay $40 million to settle an investigation in to insurance claims ...

Merck bags alternatives on Evaxion's AI-designed injection prospects

.Merck &amp Co. has grabbed options on two Evaxion Biotech injection prospects, paying $3.2 thousand...

Enanta's RSV antiviral crushes virus-like lots in challenge study

.Enanta Pharmaceuticals has connected its respiratory system syncytial infection (RSV) antiviral to ...

Biogen containers SAGE-324 collaboration after crucial shake stop working

.Biogen has actually provided the last rites to its collaboration with Sage Therapeutics on SAGE-324...

AbbVie Parkinson's drug from $8.7 B Cerevel purchase scores

.On the very same day that some Parkinson's ailment medicines are actually being brought into questi...

Arch finalizes $3B-plus fund to foster biopharma upstarts

.On the heels of a $3 billion fund coming from Bain Resources Lifestyle Sciences, Arc Endeavor Allie...

Orion to use Aitia's 'digital identical twins' to discover brand-new cancer cells medications

.Finnish biotech Orion has actually snooped potential in Aitia's "electronic double" tech to create ...

Windtree's surprise med brings up high blood pressure in most recent stage 2 win

.While Windtree Rehabs has had a hard time to develop the financial roots needed to have to make it ...

2 cancer biotechs combine, creating global impact

.OncoC4 is taking AcroImmune-- and also its own internal medical production functionalities-- under ...

Amgen files very first stage 3 win for $400M dermatitis medication

.Amgen has shared (PDF) the 1st period 3 information on its $400 thousand chronic eczema medication,...

Biogen, UCB report stage 3 lupus succeed after falling short earlier test

.Biogen and UCB's bank on advancing right into stage 3 on the back of a failed study seeks to have p...

Aptadir hopes brand-new RNA inhibitors may turn around complicated cancers cells

.Italian biotech Aptadir Therapeutics has introduced with the assurance that its own pipeline of pre...

Wave surfs DMD results to regulators' doors, sending out stock up

.Surge Life Sciences has actually satisfied its own goal in a Duchenne muscular dystrophy (DMD) rese...

Sanofi plucks brand-new CSO coming from in-stealth biotech

.After a handful of years in biotech, Mike Quigley, Ph.D., is actually going back to the pharma laye...

Achilles trickles cell therapy plan, braces for unemployments after missing out on 'office viability' targets

.Achilles Therapies has wrecked its own technique. The English biotech is quiting working on its own...

Aligos declares phase 2 MASH succeed, lowering liver fat approximately 46%

.Aligos Rehabs is actually advertising a midstage win in metabolic-dysfunction associated steatohepa...

Basilea credit ratings $268M BARDA backing for antifungals, prescription antibiotics

.Basilea Pharmaceutica's work building new antifungals has actually received a substantial boost com...

Capricor markets Europe rights to late-stage DMD therapy for $35M

.Possessing actually gathered up the united state liberties to Capricor Therapeutics' late-stage Duc...

FDA fragments adcomm for Applied's uncommon illness medicine

.After pushing back the decision meeting for Applied Rehabs' metabolic ailment medication govorestat...

Novo inks $600M NanoVation bargain to examine hereditary medicines ex-liver

.Novo Nordisk is proceeding its press right into hereditary medications, accepting pay NanoVation Th...